| 2025-11-27 |
复牌提示：
2025-11-26 14:58:21 停牌，复牌日期 2025-11-26 15:03:21
|
| 2025-11-18 |
财报披露：
美东时间 2025-11-18 盘前发布财报
|
| 2025-11-17 |
详情>>
股本变动：
变动后总股本3038.86万股
|
| 2025-11-17 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-2.39美元,归母净利润-7334.3万美元,同比去年增长-2132.22%
|
| 2025-07-31 |
详情>>
业绩披露：
2025年中报每股收益-0.98美元,归母净利润-3042.9万美元,同比去年增长-2579.95%
|
| 2025-07-24 |
详情>>
业绩披露：
2025年一季报每股收益-0.33美元,归母净利润-1039.6万美元,同比去年增长-104060%
|
| 2025-07-24 |
详情>>
业绩披露：
2024年年报每股收益0.09美元,归母净利润299.40万美元,同比去年增长-69.24%
|
| 2025-06-05 |
详情>>
内部人交易：
MOORHEAD DANIEL J共交易2笔
|
| 2025-03-28 |
股东大会：
将于2025-05-15召开股东大会
会议内容 ▼▲
- 1.To elect as directors the four nominees named in the Proxy Statement as directors;
2.To ratify the selection of CBIZ CPAs P.C. as our independent registered public accounting firm to audit the consolidated financial statements of Zynex, Inc. for our fiscal year ending December 31, 2025;
3.To consider and transact such other business as may be properly brought before the Annual Meeting and any adjournments thereof.
|
| 2024-10-24 |
详情>>
业绩披露：
2024年三季报(累计)每股收益0.11美元,归母净利润360.90万美元,同比去年增长-57.63%
|
| 2024-07-25 |
详情>>
业绩披露：
2024年中报每股收益0.04美元,归母净利润122.70万美元,同比去年增长-75.08%
|
| 2024-04-30 |
详情>>
业绩披露：
2024年一季报每股收益0.00美元,归母净利润1.00万美元,同比去年增长-99.36%
|
| 2024-04-01 |
股东大会：
将于2024-05-16召开股东大会
会议内容 ▼▲
- 1.To elect as directors the four nominees named in the Proxy Statement as directors;
2.To ratify the selection of Marcum LLP as our independent registered public accounting firm to audit the consolidated financial statements of Zynex, Inc. for our fiscal year ending December 31, 2024;
3.To consider and transact such other business as may be properly brought before the Annual Meeting and any adjournments thereof.
|
| 2024-03-12 |
详情>>
业绩披露：
2023年年报每股收益0.27美元,归母净利润973.20万美元,同比去年增长-42.91%
|
| 2023-10-26 |
详情>>
业绩披露：
2023年三季报(累计)每股收益0.24美元,归母净利润851.70万美元,同比去年增长-11.24%
|
| 2023-07-27 |
详情>>
业绩披露：
2023年中报每股收益0.13美元,归母净利润492.30万美元,同比去年增长4.23%
|
| 2023-03-30 |
股东大会：
将于2023-05-17召开股东大会
会议内容 ▼▲
- 1.To elect as directors the four nominees named in the Proxy Statement as directors;
2.To conduct an advisory vote on the compensation of our named executive officers (Say-on-Pay);
3.To ratify the selection of Marcum LLP as our independent registered public accounting firm to audit the consolidated financial statements of Zynex, Inc. for our fiscal year ending December 31, 2023;
4.To consider and transact such other business as may be properly brought before the Annual Meeting and any adjournments thereof.
|
| 2022-04-01 |
股东大会：
将于2022-05-19召开股东大会
会议内容 ▼▲
- 1.to elect as directors the four nominees named in the Proxy Statement as directors;
2.to ratify the selection of Plante & Moran, PLLC as our independent registered public accounting firm to audit the consolidated financial statements of Zynex, Inc. for our fiscal year ending December 31, 2022;
3.to consider and transact such other business as may be properly brought before the Annual Meeting and any adjournments thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-02 |
股东大会：
将于2021-05-20召开股东大会
会议内容 ▼▲
- 1.to elect as directors the four nominees named in the Proxy Statement as directors;
2.to ratify the selection of Plante & Moran, PLLC as our independent registered public accounting firm to audit the consolidated financial statements of Zynex, Inc. for our fiscal year ending December 31, 2021;
3.to consider and transact such other business as may be properly brought before the Annual Meeting and any adjournments thereof.
|
| 2020-04-02 |
股东大会：
将于2020-05-20召开股东大会
会议内容 ▼▲
- 1.to elect as directors the four nominees named in the Proxy Statement as directors
2.to conduct an advisory vote on the compensation of our named executive officers (Say-on-Pay)
3.to conduct an advisory vote on the frequency of the vote on the compensation of our named executive officers, to be held every year, every two years or every three years (Say-on-Pay Frequency)
4.to ratify the selection of Plante & Moran, PLLC as our independent registered public accounting firm to audit the consolidated financial statements of Zynex, Inc. for our fiscal year ending December 31, 2020;
5.to consider and transact such other business as may be properly brought before the Annual Meeting and any adjournments thereof.
|